Tivic Health Systems, INC Form 4 insider transactions
Insider transactions: buys and sells by directors, officers and ten percent owners, filed within two business days of the trade.
NASDAQ
Valion Bio, Inc. reports insider transactions involving Chief Financial Officer Lisa G. Wolf acquiring 92 shares of common stock.
NASDAQ
Valion Bio CEO Michael Handley acquired 2,206 shares of common stock through the vesting of restricted stock units.
NASDAQ
Melinda Lackey, General Counsel & SVP of Legal at Valion Bio, Inc., reported the acquisition of employee stock options.
NASDAQ
Director Sheryle Bolton purchased 10,000 shares of Tivic Health Systems, Inc. (TIVC) at a price of $1.04 per share.
NASDAQ
Director Christina Rizopoulos Valauri purchased 19,000 shares of Tivic Health Systems, Inc. common stock at $0.9478 per share.
NASDAQ
Tivic Health Systems' Chief Financial Officer, Lisa G. Wolf, acquired 92 shares of common stock through the vesting of Restricted Stock Units.
NASDAQ
Tivic Health Systems CFO Lisa G. Wolf reported the vesting and tax-related sale of common stock following the conversion of Restricted Stock Units.
NASDAQ
Tivic Health Systems, Inc. CEO Jennifer Ernst reported the vesting of 14,706 Restricted Stock Units and the subsequent sale of 5,262 shares to cover tax obligations.
NASDAQ
Tivic Health Systems, Inc. CEO Jennifer Ernst acquired 22,541 shares of common stock, increasing her direct beneficial ownership to 23,247 shares.
NASDAQ
Tivic Health Systems' CFO Lisa G Wolf filed an amended Form 4 to correct an administrative error regarding her stock option vesting schedule.
NASDAQ
Tivic Health Systems' Chief Operating Officer, Michael K. Handley, filed an amended Form 4 to correct the vesting schedule for 45,000 employee stock options.
NASDAQ
Tivic Health Systems' CEO, Jennifer Ernst, filed an amended Form 4 to correct an administrative error in her stock option vesting schedule.
NASDAQ
Tivic Health Systems Director Dean Zikria was granted 7,500 stock options with an exercise price of $3.32, vesting over one year.
NASDAQ
Tivic Health Systems' Chief Financial Officer, Lisa G. Wolf, was granted 80,000 employee stock options with a four-year vesting schedule.
NASDAQ
Tivic Health Systems Director Christina Rizopoulos Valauri was granted 7,500 stock options with a $3.32 exercise price, vesting over one year from August 6, 2025.
NASDAQ
Tivic Health Systems, Inc. Chief Operating Officer Michael K. Handley was granted 45,000 employee stock options with an exercise price of $3.32 per share.
NASDAQ
Tivic Health Systems, Inc. CEO Jennifer Ernst was granted 85,000 employee stock options with a $3.32 exercise price, vesting over four years.
NASDAQ
Tivic Health Systems, Inc. director Sheryle Bolton was granted 12,500 stock options with an exercise price of $3.32, vesting over one year.
NASDAQ
Michael Handley, Chief Operating Officer of Tivic Health Systems, was granted 600,000 restricted stock units (RSUs) as a material inducement for his hiring.
NASDAQ
Dean Zikria, a director of Tivic Health Systems, acquired stock options exercisable for 12,000 shares of common stock.
NASDAQ
Blake Gurfein, Chief Scientific Officer of Tivic Health Systems, received 225,000 Restricted Stock Units (RSUs) on December 18, 2024, according to a recent SEC filing.
NASDAQ
Tivic Health Systems' CEO, Jennifer Ernst, received 500,000 restricted stock units (RSUs) on December 18, 2024, which vest over a three-year period.
NASDAQ
Lisa G. Wolf, Interim CFO of Tivic Health Systems, acquired 25,000 Restricted Stock Units (RSUs) on December 18, 2024, according to a Form 4 filing with the SEC.
NASDAQ
Director Sheryle Bolton acquired 15,000 stock options in Tivic Health Systems, Inc. on December 18, 2024.
NASDAQ
Christina Rizopoulos Valauri, a director at Tivic Health Systems, acquired stock options exercisable for 12,000 shares of common stock on December 18, 2024.
NASDAQ
Karen Drexler, a director of Tivic Health Systems, Inc., resigned from her position on the Board of Directors effective September 30, 2024.
NASDAQ
Kimberly Ann Bambach, Interim CFO of Tivic Health Systems, resigned effective October 1, 2024, ceasing her obligation to report transactions in the company's equity securities.
NASDAQ
Christina Rizopoulos Valauri, a director at Tivic Health Systems, acquired stock options on August 9, 2024.
NASDAQ
Sheryle Bolton, a director at Tivic Health Systems, acquired stock options for 3,000 shares on August 9, 2024, according to a Form 4 filing.
NASDAQ
Dean Zikria, a director of Tivic Health Systems, acquired stock options for 3,000 shares at an exercise price of $0.41 on August 9, 2024.